The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.


Autoria(s): Dignass A.; Van Assche G.; Lindsay J.O.; Lémann M.; Söderholm J.; Colombel J.F.; Danese S.; D'Hoore A.; Gassull M.; Gomollón F.; Hommes D.W.; Michetti P.; O'Morain C.; Oresland T.; Windsor A.; Stange E.F.; Travis S.P.; European Crohn's; Colitis Organisation (ECCO)
Data(s)

2010

Identificador

https://serval.unil.ch/?id=serval:BIB_65457A0276C2

isbn:1876-4479 (Electronic)

pmid:21122489

doi:10.1016/j.crohns.2009.12.002

isiid:000275649100003

Idioma(s)

en

Fonte

Journal of Crohn's and Colitis, vol. 4, no. 1, pp. 28-62

Palavras-Chave #Adrenal Cortex Hormones/therapeutic use; Adult; Aminosalicylic Acids/therapeutic use; Anti-Bacterial Agents/therapeutic use; Anti-Inflammatory Agents/adverse effects; Anti-Inflammatory Agents/therapeutic use; Antibodies, Monoclonal/therapeutic use; Child; Constriction, Pathologic/surgery; Crohn Disease/pathology; Crohn Disease/therapy; Diet Therapy; Humans; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; Intestines/surgery; Methotrexate/therapeutic use; Purines/therapeutic use; Recurrence; Remission Induction; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Tipo

info:eu-repo/semantics/review

article